Story

Hims & Hers Stock Falls as Weight-Loss Drug Costs Squeeze Profit Margins

ENTHMSVIIDZHZH-TWJAKOHI
Aug 11, 20261 min read
Hims & Hers Stock Falls as Weight-Loss Drug Costs Squeeze Profit Margins
Text size
Background

Shares of Hims & Hers Health Inc. (HIMS) fell sharply on Tuesday after the company's costly expansion into the weight-loss drug market squeezed profit margins and resulted in a quarterly loss, overshadowing strong revenue and subscriber growth.

The stock dropped nearly 7% in premarket trading as investors weighed the costs of the company's aggressive growth strategy.

Growth at a Cost

Hims & Hers reported second-quarter revenue on Monday that beat Wall Street expectations and announced it had added more than 300,000 subscribers. Despite the top-line strength, the company swung to a net loss for the quarter, compared to a profit in the same period a year earlier.

The primary concern for investors was the erosion of profitability. The company's push into branded GLP-1 weight-loss drugs and its international expansion drove up costs, leading to a decline in gross margins for the fourth consecutive quarter. Reflecting this trend, Hims & Hers raised its full-year 2026 revenue forecast but trimmed the top end of its outlook for adjusted core earnings.

Sample IUX Markets – In-articleAd

Margin Outlook

Company executives acknowledged the financial trade-off. "As branded weight loss products and international revenue become a larger portion of the business, we expect gross margins will remain below the levels we have historically achieved," Chief Financial Officer Oluyemi Okupe said on an analyst call, as reported by Reuters.

Analysts noted the challenge facing the company. Morningstar's Keonhee Kim said the impressive subscriber growth was not enough to overlook the continued margin decline. Leerink Partners analyst Michael Cherny told clients there is a "tough balance between spending to grow and growth," which kept his firm's optimism limited.

Read next

More on Stocks
Back to latest news

LATEST